Trial Profile
A Japan-based phase I trial of forigerimod.
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2011
Price :
$35
*
At a glance
- Drugs Forigerimod (Primary)
- Indications Systemic lupus erythematosus
- Focus Adverse reactions; Therapeutic Use
- 03 Nov 2011 Status changed from planning to not yet recruiting.
- 16 Jun 2010 New trial record